Terms: = Pancreatic cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1
6 results:
1. Dynamic Interplay between Structural Variations and 3D Genome Organization in pancreatic cancer.
Du Y; Gu Z; Li Z; Yuan Z; Zhao Y; Zheng X; Bo X; Chen H; Wang C
Adv Sci (Weinh); 2022 Jun; 9(18):e2200818. PubMed ID: 35570408
[TBL] [Abstract] [Full Text] [Related]
2. Recurrence of Non-functional pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden-Based Prediction Model.
Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM
World J Surg; 2021 Jul; 45(7):2134-2141. PubMed ID: 33768309
[TBL] [Abstract] [Full Text] [Related]
3. FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan.
Matsumoto I; Kamei K; Omae K; Suzuki S; Matsuoka H; Mizuno N; Ozaka M; Ueno H; Kobayashi S; Uesugi K; Kobayashi M; Todaka A; Fukutomi A
Pancreatology; 2019 Mar; 19(2):296-301. PubMed ID: 30638853
[TBL] [Abstract] [Full Text] [Related]
4. DUB3 Promotes BET Inhibitor Resistance and cancer Progression by Deubiquitinating BRD4.
Jin X; Yan Y; Wang D; Ding D; Ma T; Ye Z; Jimenez R; Wang L; Wu H; Huang H
Mol Cell; 2018 Aug; 71(4):592-605.e4. PubMed ID: 30057199
[TBL] [Abstract] [Full Text] [Related]
5. Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy.
Okano K; Murakami Y; Nakagawa N; Uemura K; Sudo T; Hashimoto Y; Kondo N; Takahashi S; Sueda T
Surgery; 2016 Mar; 159(3):885-92. PubMed ID: 26603844
[TBL] [Abstract] [Full Text] [Related]
6. Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms.
Koh YX; Zheng HL; Chok AY; Tan CS; Wyone W; Lim TK; Tan DM; Goh BK
Surgery; 2015 Mar; 157(3):496-509. PubMed ID: 25656693
[TBL] [Abstract] [Full Text] [Related]
